Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Hims & Hers Health, Inc. Class A Common Stock
(NY:
HIMS
)
33.14
+1.60 (+5.07%)
Official Closing Price
Updated: 7:00 PM EDT, Mar 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Hims & Hers Health, Inc. Class A Common Stock
< Previous
1
2
3
4
5
6
Next >
Defiance Launches RKLX and HIMZ: 2X Leveraged ETFs for Rocket Lab and Hims & Hers
March 13, 2025
From
Defiance ETFs
Via
GlobeNewswire
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
February 24, 2025
From
Hims & Hers
Via
Business Wire
Hims & Hers Acquires US-based Peptide Facility
February 21, 2025
From
Hims & Hers
Via
Business Wire
Hims & Hers Acquires At-Home Lab Testing Facility, Expanding Capabilities to Ultimately Include Affordable Whole Body Testing for Subscribers
February 19, 2025
From
Hims & Hers
Via
Business Wire
Hims & Hers Launches Health Collective and Community Member Council
February 04, 2025
From
Hims & Hers
Via
Business Wire
Hims & Hers to Announce Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025
February 03, 2025
From
Hims & Hers
Via
Business Wire
The Shape of America 2024: Hims & Hers Shares an In-Depth Look Into How Americans Feel About Weight
December 12, 2024
From
Hims & Hers
Via
Business Wire
Hims & Hers Named to Inc.’s 2024 Best in Business List in Health Products Category
December 03, 2024
From
Hims & Hers
Via
Business Wire
Hims & Hers Expands Nutrition Support to Fuel Customers’ Weight Loss Journeys
November 21, 2024
From
Hims & Hers
Via
Business Wire
Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions
November 18, 2024
From
Hims & Hers
Via
Business Wire
Americans Continue to Struggle to Access Branded GLP-1s as Shortages Continue
November 13, 2024
From
Hims & Hers
Via
Business Wire
Hims & Hers Health, Inc. Reports Third Quarter 2024 Financial Results
November 04, 2024
From
Hims & Hers
Via
Business Wire
How Compounded Treatments Are Helping Hims & Hers Customers Meet Their Weight Loss Goals
October 29, 2024
From
Hims & Hers
Via
Business Wire
Top 3 Stocks Institutions Are Buying Right Now
October 28, 2024
Despite the stock market trading at new all-time highs, institutions still find enough reason to buy more enormous stakes in three stocks.
Via
MarketBeat
Hims & Hers names Dr. Jessica Shepherd as Chief Medical Officer of Hers
October 21, 2024
From
Hims & Hers
Via
Business Wire
Hims & Hers to Announce Third Quarter 2024 Financial Results on November 4, 2024
October 14, 2024
From
Hims & Hers
Via
Business Wire
Top 3 Stocks with Explosive Call Option Activity: What to Watch
October 10, 2024
Three stocks reported a surge in call option buying recently, showing investors that there could be a path to more upside potential, analysts agree
Via
MarketBeat
Hims & Hers Stock Joins S&P 600: Is More Upside on the Horizon?
October 08, 2024
There is now a new reason to look into Hims & Hers stock for additional upside, including the new addition to the S&P 600 index alongside double-digit growth.
Via
MarketBeat
Topics
Stocks
Exposures
US Equities
Hims & Hers to Offer Access to Compounded GLP-1 Injections for as Low as $99/Month to U.S. Military, Veterans, Teachers, Nurses and First Responders
September 18, 2024
From
Hims & Hers
Via
Business Wire
Invest While You Can: Pullbacks on These 3 Stocks Won’t Last Long
September 10, 2024
Three stocks stand out for investors to consider as they recently had big selloffs. There are fundamental reasons to believe that these discounts won't last
Via
MarketBeat
Topics
Economy
Exposures
Economy
Interest Rates
Top 3 Stocks to Watch: Options Traders Bet on Big Gains
August 13, 2024
Three stocks have stood out for call option traders to bet on in the coming months as a view for a recovery rally after an S&P 500 sell-off last week
Via
MarketBeat
Topics
Stocks
Exposures
US Equities
MarketBeat Week in Review – 8/5 - 8/9
August 10, 2024
Stocks were looking for direction to end the week, but next week may bring more volatility with the latest reading on inflation and the start of retail earnings
Via
MarketBeat
Topics
Economy
Exposures
Economy
Interest Rates
Hims & Hers Reports Stellar Quarter: Stock Set for a Rally
August 06, 2024
Hims & Hers stock is showing the market why its fair value is double-digits above where it trades today, with Wall Street analysts to agree
Via
MarketBeat
Topics
Bonds
ETFs
Exposures
Debt Markets
Hims & Hers Health, Inc. Reports Second Quarter 2024 Financial Results
August 05, 2024
From
Hims & Hers
Via
Business Wire
Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
August 03, 2024
Hims & Hers stock is looking like a worthy dip to watch in the coming months, especially as its decline had nothing to do with company operations
Via
MarketBeat
Can the New CEO Revive This Struggling Telehealth Stock?
July 24, 2024
Virtual healthcare provider Teladoc Health Inc. (NYSE: TDOC) stock is trading down 57.8% year-to-date (YTD). The collapse occurred after reporting Q4 2023
Via
MarketBeat
Topics
Earnings
Exposures
Financial
Pharmaceutical Industry Chief Kåre Schultz Joins Hims & Hers Board
July 22, 2024
From
Hims & Hers
Via
Business Wire
Is This Telehealth Stock a Buy After the Recent Pullback?
July 19, 2024
Hims & Hers Health leverages telehealth's accessibility to disrupt traditional healthcare and deliver personalized wellness solutions.
Via
MarketBeat
Hims & Hers to Announce Second Quarter 2024 Financial Results on August 5, 2024
July 15, 2024
From
Hims & Hers
Via
Business Wire
Eli Lilly's Stock Surge Driven by GLP-1 Demand
June 20, 2024
Shares of Eli Lilly stock are about to hit a new all-time high, sponsored by the pending approval of new weight loss drugs
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.